Company Filing History:
Years Active: 2022
Title: Éric Cabannes: Innovator in Nucleic Acid Research
Introduction
Éric Cabannes is a notable inventor based in Antony, France. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid research. His innovative work has led to advancements in the isolation and analysis of infectious agents.
Latest Patents
Éric Cabannes holds a patent titled "Modulation of accessibility of host nucleic acids to nucleic acid digesting enzymes in acellular biological fluids." This patent discloses a method for isolating, amplifying, and sequencing the nucleic acids of infectious agents from an acellular fraction of biological fluid. The method utilizes detergents and nucleic acid-digesting enzymes to enhance the accessibility of these nucleic acids. Additionally, the patent includes a kit-of-parts that comprises detergents and nucleic acid-digesting enzymes for implementing the described methods. He has 1 patent to his name.
Career Highlights
Éric Cabannes is currently associated with Pathoquest, a company that focuses on innovative solutions for the detection of infectious diseases. His role at Pathoquest allows him to apply his expertise in nucleic acid research to develop cutting-edge technologies that can improve diagnostic processes.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Éric Cabannes is a prominent figure in the field of nucleic acid research, with a patent that showcases his innovative approach to isolating and analyzing infectious agents. His work at Pathoquest continues to contribute to advancements in medical diagnostics.